Diversity of Fungi and Fungal Infections

Slides:



Advertisements
Similar presentations
Fungal Infections, Pathogenesis and Treatment
Advertisements

OPPORTUNISTIC FUNGAL INFECTIONS
FUNGAL INFECTIONS Traditionally have been divided into two distinct classes: systemic and superficial.
Anti-fungal agents Fungal infections to a large extent are iatrogenic in nature. Fungal infections are associated with the use of broad spectrum antibiotic,
Fungal Diseases March 24 th, Fungi fundamentals Occupy almost every ecological niche Exist in two forms: Yeasts –Single celled Molds –Growth in.
Fungi Plant-like organisms that lack chlorophyll 1 of the 5 Kingdoms
Chapter 91 Antifungal Agents 1.
Antifungal Drugs.
Before and after slides: -Less text and bullets-more pictures -Make pictures the center and not the text -Use nice large high-definition pictures -No more.
Chapter 7 Fungal Classification, Structure, and Replication
ANTIFUNGAL DRUGS.
ANTIFUNGAL DRUGS Fungal infections (mycoses) can be both superficial and systemic. Superficial infections (Oral and vulvovaginal candidiasis, Dermatophytosis,
Antifungal agents Mycotic Infections: Cutaneous Subcutaneous
Antifungal Drugs I. Humans and fungi share a common biosynthetic pathway for sterols from squalene (via squalene 2,3 epoxidase and other enzymes) to lanosterol.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Lecture Title: Fungal Infections of Central Nervous System
Pharmacology-4 PHL 425 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Quick Anti-fungals By Sarah E.. Anti-fungals Name the 6 categories of anti-fungals 1.Polyenes 2.-azoles 3.Synthetic allylamines 4.Anti-metabolites 5.Echinocandins.
ANTIFUNGAL AGENTS subhash k. mohan UHN – TML & Mount Sinai Hospital.
Combination Antifungal Therapy By Amy Barnett, Doctor of Pharmacy Candidate University of Florida College of Pharmacy.
Recommended text books
Fungal infections 400 out of 75,000 Primary infections Opportunistic infections Myco-toxins Allergy.
Antifungal Drugs.
PHPR 202: ANTIFUNGAL THERAPY Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University School of Pharmacy.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2011 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 41 Antifungal Drugs.
Diagnosis 1. Wet Mount 2. Skin test 3. Serology 4. Fluorescent antibody 5. Biopsy and histopathology 6. Culture 7. DNA probes.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012
Antifungal Agents.
ANTIFUNGAL DRUGS Modes of Action Mechanisms of Resistance
NAJRAN UNIVERSITY College of Applied Medical Sciences NAJRAN UNIVERSITY College of Applied Medical Sciences General Microbiology Course Lecture No. 23.
Diversity of Fungi and Fungal Infections
By Dr.Mohamed Abd AlMoneim Attia
Introduction to Mycology Nov. 30, 2015 Bob Slinger, MD, Division of Infectious Disease, CHEO.
Mycology Lec. 2 Dr. Manahil
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Systemic & Topical Some are fungistatic, while others are fungicidal.
RESPIRATORY FUNGAL INFECTION. YEASTMOULD FUNGIDIMORPHIC FUNGI OpportunisticPrimary Infectious Candidiasis (Candida and other yeast) Aspergillosis (Aspergillus.
Dr C Sriruttan Clinical Microbiology & Infectious Disease /11/20161 Principles & Approach.
5. Antifungal Agents Pharmacognosy IV PHG 423 Dr/ Abdulaziz Saeedan Pharmacy College 1.
University of Karbala College of veterinary medicine Second semester Pharmacology Lect. # 2 Antifungal Drugs Dr. Sattar K. Abdul-Hussain, Ph.D, DVM, DABT.
Introduction to Medical Mycology
PHARMACEUTICAL MICROBIOLOGY -I PHT 226
ANTIFUNGAL DRUGS.
By Dr.Mohamed Abd AlMoneim Attia
Lecture Title: Fungal Infections of Central Nervous System
Antifungal drugs Lec Dr. Naza M. Ali
Antifungal Drugs.
Introduction to Medical Mycology
Antifungal drugs.
Brielle Haas RISE Spring 2015 Dr. Gullo
Sites of action of antifungal drugs
PHARMACEUTICAL MICROBIOLOGY I PHT 226
Respiratory Fungal Infections
Antifungal drugs Lec Dr. Naza M. Ali
Copyright © 2017, Elsevier Inc. All rights reserved.
Anti-fungal agents Problem: Fungi are eukaryotes
Mycology.
Fungal endophthalmitis
Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature.
Antifungal agents.
Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature.
FUNGI David Dockrell Professor of Infectious Diseases
Antifungals 20 November :58 AM.
School of Pharmacy, University of Nizwa
Current Concepts in Antifungal Pharmacology
Antifungal Agents “Antifungal agents are the drugs used against fungal infection and can be either fungistatic or fungicidal.”
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2018
Lecturer name: Dr. Ahmed M. Albarrag
Presentation transcript:

Diversity of Fungi and Fungal Infections Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)

Lecture Objectives.. To provide students with an overview of the common medically important yeasts and mold fungi. 2. To provide students with an overview of the major fungal diseases that threatens human health. 3. To give a fundamental knowledge about the antifungal agents, their mechanisms of action, and spectrum.

Hypersensitivity (Allergy) Mycotoxicoses Infections Mycotic Diseases Hypersensitivity (Allergy) Mycotoxicoses Infections 3

Mycotic Diseases How the infection is acquired? Endogenous, Colonization (overgrowth of normal flora) Inhalation (Airborne) Contact Trauma 4

Types of fungal infections ( Mycoses) Superficial mycoses Cutaneous mycosis Subcutaneous mycoses Systemic mycoses Opportunistic mycoses 5 5

Types of fungal infections - Mycoses Superficial Mycoses Affect the outer layer of the skin or hair shaft No immune response Cutaneous Mycoses Dermatophytosis Infection of the skin, hair or nails caused by a group of keratinophilic fungi, called dermatophytes 6 6

Types of fungal infections - Mycoses Subcutaneous Mycoses Fungal infections involving the dermis, subcutaneous tissues, muscle and may extend to bone. Usually they are initiated by trauma. 7 7

Types of fungal infections - Mycoses Primary Systemic Mycoses Caused by primary pathogens Contracted by inhalation, Start as respiratory disease Geographically restricted (endemic), north and south America 8 8

Types of fungal infections - Mycoses Opportunistic fungal infections Diseases in immunocompromised host Risk factors Examples: HIV/AIDS Hematopoietic stem cell transplant (HSCT) Solid organs transplantation Malignancies Neutropenia Diabetes Many others 9 9

The Fungi B) Primary Pathogens A) Opportunistic Fungi Dermatophytes Endemic geographically restricted - Histoplasma spp. - Blastomyces spp. Coccidioides spp. Paracoccidioides spp A) Opportunistic Fungi Normal flora Candida spp. Other yeast Ubiquitous in our environment Aspergillus spp. Zygomycetes spp. • Other fungi 10 10

Diagnosis of fungal infection Clinical features (clinical presentation) History, risk factors, etc. Imaging Good value in diagnosis and therapy monitoring Lab Investigations Histopathology Microbiology 11

Antifungal agents 12 12

Targets for antifungal agents Cell membrane • Polyene • Azole Cell wall • Echinocandins Caspofungin Micafungin Anidulafungin DNA/RNA synthesis Pyrimidine analogues - Flucytosine 13 13

Polyenes Mechanism of Action Amphotericin B (MOA): Amphotericin B, lipid formulations Nystatin Mechanism of Action Amphotericin B (MOA): Binds to ergosterol within the fungal cell membrane resulting in formation of pores which permit leakage of intracellular contents, and lead to death . Amphotericin B has an broad antifungal spectrum which includes most fungi that cause human disease 14 14

AZOLES Mechanism of Action Fluconazole Ketoconazole Itraconazole Voriconazole Posaconazole Miconazole, clotrimazole Mechanism of Action Inhibits synthesis of ergosterol, the major sterol of fungal cell membrane. 15 15

Flucytosine Mechanism of Action Fungal RNA miscoding Interfering with DNA synthesis Spectrum of Activity (Restricted spectrum of activity) Active against Candida species Cryptococcus neoformans Monotherapy : now limited (Resistance) 16 16

Echinocandins Mechanism of Action Good activity against Caspofungin Micafungin Anidulafungin Mechanism of Action Inhibits B-1,3 –D glucan synthase, the enzyme complex that forms glucan polymers in the fungal cell wall. Glucan polymers are responsible for providing rigidity to the cell wall. Good activity against Candida spp Aspergillus spp 17 17

Comments Spectrum of activity Antifungal Agents Mechanism of action Group Target Serious toxic side effects (nephrotoxicity) Broad antifungal spectrum which includes most fungi Amphotericin B, Nystatin Binds to ergosterol within cell membrane, formation of pores which lead to cell death Polyenes Cell membrane Not effective against zygomycosis (except posaconazole) Adverse Effects Drug Interactions Fluconazole has a limited or no activity against mould fungi Voriconazol is the drug of choice for Aspergillosis Fluconazole Itraconazole Voriconazole Miconazole clotrimazole Inhibit the synthesis of ergosterol Azoles Less toxicity and side effects compared to amphotericin B and azoles Good activity against Candida spp ,Aspergillus spp Limited or no activity against other fungi Caspofungin Micafungin Anidulafungin Inhibits glucan synthasis, (glucan polymers in the fungal cell wall) Echinocandins Cell wall Monotherapy now limited (Resistance) Restricted spectrum of activity Candida species Cryptococcus neoformans Flucytosine Fungal RNA miscoding Interfering with DNA synthesis Pyrimidine analogues DNA/RNA synthesis 18

Thank You  (Foundation Block, Microbiology)